MicroRNA Profiling in the Perilymph of Cochlear Implant Patients: Identifying Markers that Correlate to Audiological Outcomes.

TitleMicroRNA Profiling in the Perilymph of Cochlear Implant Patients: Identifying Markers that Correlate to Audiological Outcomes.
Publication TypeJournal Article
Year of Publication2021
AuthorsWichova H, Shew M, Nelson-Brantley J, Warnecke A, Prentiss S, Staecker H
JournalJ Am Acad Audiol
Volume32
Issue10
Pagination627-635
Date Published2021 11
ISSN2157-3107
KeywordsCochlear Implantation, Cochlear Implants, Humans, MicroRNAs, Perilymph, Speech Perception, Treatment Outcome
Abstract

HYPOTHESIS: MicroRNA (miRNA) expression profiles from human perilymph correlate to post cochlear implantation (CI) hearing outcomes.

BACKGROUND: The high inter-individual variability in speech perception among cochlear implant recipients is still poorly understood. MiRNA expression in perilymph can be used to characterize the molecular processes underlying inner ear disease and to predict performance with a cochlear implant.

METHODS: Perilymph collected during CI from 17 patients was analyzed using microarrays. MiRNAs were identified and multivariable analysis using consonant-nucleus-consonant testing at 6 and 18 months post implant activation was performed. Variables analyzed included age, gender, preoperative pure tone average (PTA), and preoperative speech discrimination (word recognition [WR]). Gene ontology analysis was performed to identify potential functional implications of changes in the identified miRNAs.

RESULTS: Distinct miRNA profiles correlated to preoperative PTA and WR. Patients classified as poor performers showed downregulation of six miRNAs that potentially regulate pathways related to neuronal function and cell survival.

CONCLUSION: Individual miRNA profiles can be identified in microvolumes of perilymph. Distinct non-coding RNA expression profiles correlate to preoperative hearing and postoperative cochlear implant outcomes.

DOI10.1055/s-0041-1742234
Alternate JournalJ Am Acad Audiol
PubMed ID35609590
Grant ListU54 HD090216 / HD / NICHD NIH HHS / United States
P30 GM122731 / GM / NIGMS NIH HHS / United States
S10 OD021743 / OD / NIH HHS / United States
UL1 TR002366 / TR / NCATS NIH HHS / United States
P30 CA168524 / CA / NCI NIH HHS / United States
P20 GM103418 / GM / NIGMS NIH HHS / United States
Faculty Reference: 
Helena Wichova, MD